Phase I Trial of S-1153 in Patients With HIV Infection
NCT00002214
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Capravirine
Sponsor
Lexigen Pharmaceuticals